Louis R. Verdetto - 08 Sep 2026 Form 4 Insider Report for Strata Critical Medical, Inc. (SRTA)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
10 Sep 2026, 16:28:45 UTC
Prior SEC filing
04 Dec 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Melissa M. Tomkiel, Attorney-in-fact for Louis R. Verdetto

Key filing fact

Louis R. Verdetto filed Form 4 for Strata Critical Medical, Inc. (SRTA) on 10 Sep 2026.

Key facts

  • This page summarizes Louis R. Verdetto's Form 4 filing for Strata Critical Medical, Inc. (SRTA).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 10 Sep 2026, 16:28.

Change

  • Previous filing in this sequence was filed on 04 Dec 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002095962 Primary reporting owner

Verdetto Louis R.

Relationship
CEO, Clinical Services
Address
C/O STRATA CRITICAL MEDICAL, INC., 666 THIRD AVENUE, 25TH FLOOR, NEW YORK
Signature
/s/ Melissa M. Tomkiel, Attorney-in-fact for Louis R. Verdetto
Signature date
10 Sep 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SRTA transaction

Class A common stock, $0.0001 par value per share

Tax liability

Transaction value
Shares
-5,697
Change %
-0.5%
Price
$5.31*
Shares after
1,128,096
Date
08 Sep 2026
Ownership
Direct
Footnotes
F1
SRTA holding

Class A common stock, $0.0001 par value per share

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
132,232
Date
08 Sep 2026
Ownership
See Footnote
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

Footnote F2

The reported securities are held by the LOUIS VERDETTO IRREVOCABLE TRUST DATED AUGUST 20 2025 for which the Reporting Person serves as the trustee.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .